New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

After years of lobbying from patients, the first ever national lung cancer screening program will roll out next month for ...

CHICAGO -- Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

NHS England is set to introduce a pioneering liquid biopsy blood test, offering new hope to lung and breast cancer ...

Helena Yu, MD, discusses the efficacy of zipalertinib for EGFR-mutant non–small cell lung cancer and the importance of exploring therapies with CNS penetration in this space.

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

Researchers at ASCO provided a look at DB-1310 and iza-bren in genomically altered NSCLC, amid an overall survival miss for ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

The envisioned flow cytometry test will help to predict patient response to immunotherapies for five cancer indications.

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...